Evogene Ltd. current report, Q2 FY2017

Business Context and Reporting Period

This Form 6-K filing by Evogene Ltd. covers the month of June 2017, specifically dated June 20, 2017. The report serves to disseminate a press release regarding the company's Insect Control Seed Trait Program.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on operational milestones rather than financial performance data.

Material Changes

The primary material change reported is the announcement of positive results in the Insect Control Seed Trait Program. Additionally, the company reported the advancement of its first toxin against the Western corn rootworm to Phase-I.

Guidance, Outlook, and Risks

Management commentary is limited to the successful progression of the toxin development program. The filing does not contain specific financial guidance, updated outlooks, or a detailed discussion of risks and contingencies beyond the context of the press release.

Investor Verification Checklist

  • Verify the specific details of the "positive results" in the Insect Control Seed Trait Program referenced in the attached press release.
  • Confirm the timeline and criteria for the advancement of the Western corn rootworm toxin to Phase-I.
  • Review the full text of Exhibit 99.1 for any additional operational context not summarized in the filing header.